887 PHARMACOKINETICS OF SIMEPREVIR (TMC435) IN VOLUNTEERS WITH MODERATE OR SEVERE HEPATIC IMPAIRMENT

Abstract

886 IMPACT OF THE VIRAL KINETICS OF CHRONIC HEPATITIS C PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGYLATED INTERFERON a2b AND RIBAVIRIN E. Ogawa, N. Furusyo, M. Nakamuta, E. Kajiwara, H. Nomura, K. Dohmen, K. Takahashi, T. Satoh, K. Azuma, A. Kawano, Y. Tanabe, K. Kotoh, S. Shimoda, J. Hayashi, The Kyushu University Liver Disease Study (KULDS) Group. Department of General Internal Medicine, Kyushu University Hospital, Department of Gastroenterology, Kyushu Medical Center, Fukuoka, Department of Internal Medicine, Steel Memorial Yawata Hospital, The Center for Liver Disease, Shin-Kokura Hospital, Kitakyushu, Department of Internal Medicine, Chihaya Hospital, Department of Medicine, Hamanomachi Hospital, Fukuoka, Center for Liver Disease, National Hospital Organization Kokura Medical Center, Kitakyushu, Department of Medicine, Kyushu Central Hospital, Fukuoka, Department of Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Department of Medicine, Fukuoka City Hospital, Department of Medicine and Bioregulatory Science, Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan E-mail: eogawa@gim.med.kyushu-u.ac.jp